Congress authorized multidistrict litigation "for the
convenience of parties and witnesses" and to "promote the
just and efficient conduct of such actions." 28 U.S.C.
§1407(a). As we've documented in
many
posts
in
our
MDL topic, the reality – at least in product liability
mass torts involving prescription medical products – is so
far from what Congress intended as to call the entire process into
question.
Instead of convenience, we see the Rules of Civil Procedure
being ignored on a massive scale to deprive defendants of motions
practice, to postpone "case specific" defenses, and to
force defendants not only to provide massive discovery of their own
information, but also to shoulder discovery burdens, such as
collection of medical records, that should be the plaintiffs'
responsibility.